PharmaShots | Incisive News in 3 Shots

Subscribe Now

mepolizumab

GSK's Nucala (mepolizumab) Receives the US FDA's Approval as the First Treatment for Hypereosinophilic Syndrome

GSK's Nucala (mepolizumab) Receives the US FDA's Approval as the First Treatment for Hypereosinophilic Syndrome

September 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us